KPTI
Real-time Quotes | Nasdaq Last Sale
Based on 10 analysts
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 22,2021 20:09
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 22,2021 20:10
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 22,2021 20:11
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 22,2021 20:12
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 17,2021 18:45
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 17,2021 18:44
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 17,2021 18:46
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 17,2021 18:47
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 17,2021 18:48
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 17,2021 18:49
SC 13G/A Karyopharm Therapeutics Inc. (0001503802) (Subject)
Feb 17,2021 15:12
SC 13G/A Karyopharm Therapeutics Inc. (0001503802) (Subject)
Feb 16,2021 16:35
SC 13G/A Karyopharm Therapeutics Inc. (0001503802) (Subject)
Feb 16,2021 16:03
SC 13G/A Karyopharm Therapeutics Inc. (0001503802) (Subject)
Feb 16,2021 14:21
SC 13G/A Karyopharm Therapeutics Inc. (0001503802) (Subject)
Feb 12,2021 08:13
SC 13G/A Karyopharm Therapeutics Inc. (0001503802) (Subject)
Feb 11,2021 08:19
8-K Karyopharm Therapeutics Inc. (0001503802) (Filer)
Feb 11,2021 07:13
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 09,2021 21:56
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 09,2021 20:28
4 Karyopharm Therapeutics Inc. (0001503802) (Issuer)
Feb 09,2021 20:30
Webull offers kinds of Karyopharm Therapeutics Inc stock information, including NASDAQ:KPTI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KPTI stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading KPTI stock methods without spending real money on the virtual paper trading platform.